Xeljanz Cancer Risks Highlighted In Study Data

Serious Xeljanz cancer risks that have not been adequately disclosed by the drug makers have been recently uncovered in a completed study conducted by Pfizer. If earlier information and warnings had been provided for users about the Xeljanz cancer side effects, many individuals may have avoided… Read More

Harvey Kirk

By
February 8, 2021 | 1 Comment